Abstract:Background & Aims: Either activation of mTORC1 due to loss of Tsc1 (tuberous sclerosis complex 1) or defective hepatic autophagy due to loss of Atg5 leads to spontaneous liver tumorigenesis in mice. The purpose of this study was to investigate the mechanisms by which autophagy contributes to the hepatic metabolic changes and tumorigenesis mediated by mTORC1 activation. Methods: Atg5 Flox/Flox (Atg5(F/F)) and Tsc1(F/F) mice were crossed with albumin-Cre mice to generate liver-specific Atg5 knockout (L-Atg5 KO), L-Tsc1 KO and L-Atg5/Tsc1 double KO (DKO) mice. These mice were crossed with p62/Sqstm1(F/F) (p62) and whole body Nrf2 KO mice to generate L-Atg5/Tsc1/p62 and L-Atg5/Tsc1-Nrf2 triple KO mice. These mice were housed for various periods up to 12 months, and blood and liver tissues were harvested for biochemical and histological analysis Results: Deletion of Atg5 in L-Tsc1 KO mice inhibited liver tumorigenesis but increased mortality and was accompanied by drastically enhanced hepatic ductular reaction (DR), hepatocyte degeneration and metabolic reprogramming. Deletion of p62 reversed DR, hepatocyte degeneration and metabolic reprogramming as well as the mortality of L-Atg5/Tsc1 DKO mice, but unexpectedly promoted liver tumorigenesis via activation of a group of oncogenic signaling pathways. Nrf2 ablation markedly improved DR with increased hepatocyte population and improved metabolic reprogramming and survival of the L-Atg5/Tsc1 DKO mice without tumor formation. Decreased p62 and increased mTOR activity were also observed in a subset of human hepatocellular carcinomas. Conclusions: These results reveal previously undescribed functions of hepatic p62 in suppressing tumorigenesis and regulating liver cell repopulation and metabolic reprogramming resulting from persistent mTORC1 activation and defective autophagy. Lay summary: Metabolic liver disease and viral hepatitis are common chronic liver diseases and risk factors of hepatocellular carcinoma, which are often associated with impaired hepatic autophagy and increased mTOR activation. Using multiple genetically engineered mouse models of defective hepatic autophagy and persistent mTOR activation, we dissected the complex mechanisms behind this observation. Our results uncovered an unexpected novel tumor suppressor function of p62/Sqstm1, which regulated liver cell repopulation, ductular reaction and metabolic reprogramming in liver tumorigenesis. (C) 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Hepatocytic P62 Suppresses Ductular Reaction and Tumorigenesis in Mouse Livers with Mtorc1 Activation and Defective Autophagy.

SQSTM1/p62 Inhibits Whereas Nrf2 Promotes Tumorigenesis by Inducing Cell Population Remodeling and Metabolic Reprograming in Mouse Livers with Mtorc1 Activation and Defective Autophagy

An Unexpected Tumor Suppressor Role of SQSTM1/p62 in Liver Tumorigenesis

The double-edged sword of MTOR in autophagy deficiency induced-liver injury and tumorigenesis

p62 Promotes Amino Acid Sensitivity of mTOR Pathway and Hepatic Differentiation in Adult Liver Stem/Progenitor Cells

Dual Roles of Mammalian Target of Rapamycin in Regulating Liver Injury and Tumorigenesis in Autophagy‐Defective Mouse Liver

Sirt1 deacetylates and stabilizes p62 to promote hepato-carcinogenesis

The TRAF2-p62 axis promotes proliferation and survival of liver cancer by activating mTORC1 pathway

Sequestosome 1/p62-related pathways as therapeutic targets in hepatocellular carcinoma

p62 Promotes Malignancy of Hepatocellular Carcinoma by Regulating the Secretion of Exosomes and the Localization of beta-Catenin

Persistent Mtorc1 Activation Due to Loss of Liver Tuberous Sclerosis Complex 1 Promotes Liver Injury in Alcoholic Hepatitis.

Sequestosome 1/p62 Protein is Associated with Autophagic Removal of Excess Hepatic Endoplasmic Reticulum in Mice

p62-Induced Cancer-Associated Fibroblast Activation via the Nrf2-ATF6 Pathway Promotes Lung Tumorigenesis

DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1

Abstract 4455: Metabolic stress induces a double positive feedback loop between AMPK and p62 conferring dual activation of AMPK and NRF2 to synergize antioxidant defense

p62/Sqstm1 rescue in muscle retards the progression of steatohepatitis in p62/Sqstm1-null mice fed a high-fat diet

Rictor Mediates P53 Deactivation to Facilitate the Malignant Transformation of Hepatocytes and Promote Hepatocarcinogenesis.

Elevated aerobic glycolysis driven by p62-mTOR axis promotes arsenic-induced oncogenic phenotypes in human mammary epithelial cells

Degradation of helicase-like transcription factor (HLTF) by -TrCP promotes hepatocarcinogenesis via activation of the p62/mTOR axis

p62/SQSTM1 synergizes with autophagy for tumor growth in vivo

p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma